205 related articles for article (PubMed ID: 30119677)
1. Six-month safety evaluation of robenacoxib tablets (Onsior™) in dogs after daily oral administrations.
Toutain CE; Brossard P; King SB; Helbig R
BMC Vet Res; 2018 Aug; 14(1):242. PubMed ID: 30119677
[TBL] [Abstract][Full Text] [Related]
2. Safety evaluation of the interchangeable use of robenacoxib (Onsior™) tablets and solution for injection in dogs.
Toutain CE; Heit MC; King SB; Helbig R
BMC Vet Res; 2017 Nov; 13(1):359. PubMed ID: 29179750
[TBL] [Abstract][Full Text] [Related]
3. Safety evaluation of the interchangeable use of robenacoxib in commercially-available tablets and solution for injection in cats.
Heit MC; Stallons LJ; Seewald W; Thompson CM; Toutain CE; King SB; Helbig R
BMC Vet Res; 2020 Sep; 16(1):355. PubMed ID: 32988403
[TBL] [Abstract][Full Text] [Related]
4. Robenacoxib in the dog: target species safety in relation to extent and duration of inhibition of COX-1 and COX-2.
King JN; Arnaud JP; Goldenthal EI; Gruet P; Jung M; Seewald W; Lees P
J Vet Pharmacol Ther; 2011 Jun; 34(3):298-311. PubMed ID: 21492194
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of oral robenacoxib (tablet) for the treatment of pain associated with soft tissue surgery in client-owned dogs.
Friton G; Thompson CM; Karadzovska D; King S; King JN
BMC Vet Res; 2017 Jun; 13(1):197. PubMed ID: 28651573
[TBL] [Abstract][Full Text] [Related]
6. Safety of oral robenacoxib in the cat.
King JN; Hotz R; Reagan EL; Roth DR; Seewald W; Lees P
J Vet Pharmacol Ther; 2012 Jun; 35(3):290-300. PubMed ID: 21736587
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Injectable Robenacoxib for the Treatment of Pain Associated With Soft Tissue Surgery in Dogs.
Friton G; Thompson C; Karadzovska D; King S; King JN
J Vet Intern Med; 2017 May; 31(3):832-841. PubMed ID: 28514527
[TBL] [Abstract][Full Text] [Related]
8. Determination of the route of excretion of robenacoxib (Onsior™) in cats and dogs: A pilot study.
King JN; Jung M
J Vet Pharmacol Ther; 2021 May; 44(3):411-416. PubMed ID: 33881783
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the dose-response relationship of oral robenacoxib in urate crystal-induced acute stifle synovitis in dogs.
Borer LR; Seewald W; Peel JE; King JN
J Vet Pharmacol Ther; 2017 Apr; 40(2):148-157. PubMed ID: 27493016
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of subcutaneous and oral administration of robenacoxib and meloxicam for the treatment of acute pain and inflammation associated with orthopedic surgery in dogs.
Gruet P; Seewald W; King JN
Am J Vet Res; 2011 Feb; 72(2):184-93. PubMed ID: 21281192
[TBL] [Abstract][Full Text] [Related]
11. Robenacoxib versus meloxicam for the management of pain and inflammation associated with soft tissue surgery in dogs: a randomized, non-inferiority clinical trial.
Gruet P; Seewald W; King JN
BMC Vet Res; 2013 May; 9():92. PubMed ID: 23638669
[TBL] [Abstract][Full Text] [Related]
12. Can liquorice extract and herbal solution prevent colonic mucosa damage caused by robenacoxib in dogs?
Szweda M; Szarek J; Lew M; Szarek-Bęska A; Gulda D
Pol J Vet Sci; 2015; 18(4):793-8. PubMed ID: 26812822
[TBL] [Abstract][Full Text] [Related]
13. Analgesic and anti-inflammatory actions of robenacoxib in acute joint inflammation in dog.
Schmid VB; Spreng DE; Seewald W; Jung M; Lees P; King JN
J Vet Pharmacol Ther; 2010 Apr; 33(2):118-31. PubMed ID: 20444036
[TBL] [Abstract][Full Text] [Related]
14. Safety evaluation of lotilaner in dogs after oral administration as flavoured chewable tablets (Credelio™).
Kuntz EA; Kammanadiminti S
Parasit Vectors; 2017 Nov; 10(1):538. PubMed ID: 29089043
[TBL] [Abstract][Full Text] [Related]
15. Robenacoxib versus meloxicam for the control of peri-operative pain and inflammation associated with orthopaedic surgery in cats: a randomised clinical trial.
Speranza C; Schmid V; Giraudel JM; Seewald W; King JN
BMC Vet Res; 2015 Mar; 11():79. PubMed ID: 25880535
[TBL] [Abstract][Full Text] [Related]
16. Effect of benazepril and robenacoxib and their combination on glomerular filtration rate in dogs.
Panteri A; Kukk A; Desevaux C; Seewald W; King JN
J Vet Pharmacol Ther; 2017 Jan; 40(1):44-56. PubMed ID: 27302598
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of cardiovascular effects of intravenous robenacoxib in dogs.
Desevaux C; Marotte-Weyn AA; Champeroux P; King JN
J Vet Pharmacol Ther; 2017 Dec; 40(6):e62-e64. PubMed ID: 28457010
[TBL] [Abstract][Full Text] [Related]
18. Pharmacology, safety, efficacy and clinical uses of the COX-2 inhibitor robenacoxib.
Lees P; Toutain PL; Elliott J; Giraudel JM; Pelligand L; King JN
J Vet Pharmacol Ther; 2022 Jul; 45(4):325-351. PubMed ID: 35460083
[TBL] [Abstract][Full Text] [Related]
19. Clinical safety of robenacoxib in feline osteoarthritis: results of a randomized, blinded, placebo-controlled clinical trial.
King JN; King S; Budsberg SC; Lascelles BD; Bienhoff SE; Roycroft LM; Roberts ES
J Feline Med Surg; 2016 Aug; 18(8):632-42. PubMed ID: 26058587
[TBL] [Abstract][Full Text] [Related]
20. Effects of route of administration and feeding schedule on pharmacokinetics of robenacoxib in cats.
King JN; Jung M; Maurer MP; Schmid VB; Seewald W; Lees P
Am J Vet Res; 2013 Mar; 74(3):465-72. PubMed ID: 23438125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
